StonvexLoading…
StonvexStonvexStonvexCore line items from ITT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.94B | $3.63B | $3.28B | $2.99B |
Operating Income | $684.50M | $678.10M | $530.50M | $468.00M |
Net Income | $488.00M | $519.90M | $412.20M | $367.00M |
EPS (Diluted) | $6.11 | $6.32 | $4.98 | $4.38 |
Total Assets | $6.31B | $4.73B | $3.93B | $3.78B |
Total Liabilities | $2.22B | $1.95B | $1.39B | $1.52B |
Cash & Equivalents | $1.74B | $439.30M | $489.20M | $561.20M |
Free Cash Flow OCF − CapEx | $547.50M | $438.70M | $430.40M | $173.80M |
Shares Outstanding | 79.90M | 82.30M | 82.70M | 83.70M |